Metabolic Research Institute
High Quality Assessment & Medical Care . . . Teaching . . . Research

CONTACT US

  HOME


1515 N. Flagler Drive
Suite 440
West Palm Beach, FL 33401
USA

Tel:     (561) 802-3060
Fax:    (561) 802-3260
 


 

Our Brochure

Our Newsletter

Adobe Acrobat Reader is required to view these files. To download your free copy of this software click here:
 
Get Acrobat Reader


CHOLESTEROL
 


 

High Blood Pressure and Cholesterol: Dual Risk Factors for Heart Disease . . .

By Barry S. Horowitz, M.D., F.A.C.P.

High blood pressure and high cholesterol have been proven to be major risk factors for developing heart disease based on many clinical studies. Yet despite this evidence and evidence that treating both of these risk factors reduces the risk of heart disease, they remain woefully under treated. For example, only 25% of people with high blood pressure in the United States are considered to be under control.

High blood pressure has a continuum of risk. For every small degree that a person’s blood pressure is over normal (120/80), the risk of heart disease increases. This means that keeping blood pressure as close to goal as possible is essential to preventing heart disease. Some studies have even shown that only a two point drop in blood pressure can lower this risk.

Last summer, the government issued new guidelines about the treatment of high cholesterol. These guidelines are more strict than previous, as studies have shown that lower may be better as far as heart disease risk. Based on these recommendations, 37 million Americans are considered eligible for medications to lower cholesterol. This is 18% of the population!

High blood pressure and high cholesterol tend to cluster together in people and as such, increase the risk of heart disease even further. The Metabolic Research Institute is currently studying a medication that is a combination pill, using a well known cholesterol lowering medication and a popular blood pressure pill. Each medication is individually FDA approved.

For more information about this trial, contact us today:

(561) 802-3060